Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.06% is 44% above its 5-year average of 2.82%, near the high end of its 5-year range (1.20%–4.06%).
9.14% above its 12-month average of 3.72%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.28%.
RETURN ON ASSETS (ROA)
4.06%
RETURN ON ASSETS (ROA) AVG TTM
3.72%
RETURN ON ASSETS (ROA) AVG 3Y
3.23%
RETURN ON ASSETS (ROA) AVG 5Y
2.82%
RETURN ON ASSETS (ROA) AVG 10Y
3.01%
RETURN ON ASSETS (ROA) AVG 15Y
3.18%
RETURN ON ASSETS (ROA) AVG 20Y
3.98%
CURRENT VS TTM AVG
+9.14%
CURRENT VS 3Y AVG
+25.79%
CURRENT VS 5Y AVG
+43.89%
CURRENT VS 10Y AVG
+34.84%
CURRENT VS 15Y AVG
+27.54%
CURRENT VS 20Y AVG
+1.92%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+112.59%
vs the sector median at left
HealthStream, Inc.
Market Cap
$914.73M
Return on Assets (ROA)
4.06%
TTM Avg
3.72%
3Y Avg
3.23%
5Y Avg
2.82%
Market Cap
$921.06M
Return on Assets (ROA)
-45.94%
TTM Avg
-39.23%
3Y Avg
-37.58%
5Y Avg
-117.41%
Market Cap
$923.53M
Return on Assets (ROA)
-39.67%
TTM Avg
-22.62%
3Y Avg
-34.56%
5Y Avg
-34.56%
Market Cap
$929.83M
Return on Assets (ROA)
-30.07%
TTM Avg
-30.07%
3Y Avg
-30.07%
5Y Avg
-30.07%
Market Cap
$934.79M
Return on Assets (ROA)
-50.49%
TTM Avg
-30.32%
3Y Avg
-31.10%
5Y Avg
-27.11%
Market Cap
$887.99M
Return on Assets (ROA)
-22.62%
TTM Avg
-55.95%
3Y Avg
-57.94%
5Y Avg
-46.38%
Market Cap
$887.50M
Return on Assets (ROA)
8.09%
TTM Avg
-0.64%
3Y Avg
-8.03%
5Y Avg
-4.54%
Market Cap
$884.97M
Return on Assets (ROA)
55.85%
TTM Avg
-44.25%
3Y Avg
-43.62%
5Y Avg
-43.05%
Market Cap
$952.91M
Return on Assets (ROA)
-72.50%
TTM Avg
-45.97%
3Y Avg
-37.50%
5Y Avg
-37.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $914.73M | 4.06% | 3.72% | 3.23% | 2.82% |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | -45.94% | -39.23% | -37.58% | -117.41% |
| CeriBell, Inc. (CBLL)vs › | $923.53M | -39.67% | -22.62% | -34.56% | -34.56% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | -30.07% | -30.07% | -30.07% | -30.07% |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | -50.49% | -30.32% | -31.10% | -27.11% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | -22.62% | -55.95% | -57.94% | -46.38% |
| Bioventus Inc. (BVS)vs › | $887.50M | 8.09% | -0.64% | -8.03% | -4.54% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 55.85% | -44.25% | -43.62% | -43.05% |
| Savara Inc. (SVRA)vs › | $952.91M | -72.50% | -45.97% | -37.50% | -37.52% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -13.12% | -18.77% | -18.48% | -18.48% |
ROA
4.1%
ROE
5.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.52% |
| 2024-12-31 | 3.92% |
| 2023-12-31 | 3.04% |
| 2022-12-31 | 2.43% |
| 2021-12-31 | 1.20% |
| 2020-12-31 | 2.82% |
| 2019-12-31 | 3.22% |
| 2018-12-31 | 7.32% |
| 2017-12-31 | 2.43% |
| 2016-12-31 | 0.95% |
| 2015-12-31 | 2.27% |
| 2014-12-31 | 4.04% |
| 2013-12-31 | 3.96% |
| 2012-12-31 | 4.38% |
| 2011-12-31 | 4.50% |
| 2010-12-31 | 5.07% |
| 2009-12-31 | 19.68% |
| 2008-12-31 | 5.41% |
| 2007-12-31 | 7.66% |
| 2006-12-31 | 6.10% |
| 2005-12-31 | 5.43% |
| 2004-12-31 | -3.67% |
| 2003-12-31 | -12.01% |
| 2002-12-31 | -50.56% |
| 2001-12-31 | -39.75% |
| 2000-12-31 | -28.79% |
| 1999-12-31 | -25.71% |
